OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
26
Results
Show all
Save search
Copy query
Show results for
Unknown
(26)
Publication Date
Release Date
2023
(7)
2021
(5)
2022
(4)
2025
(2)
2016
(2)
2015
(2)
2024
(1)
2020
(1)
2018
(1)
2011
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Adeno-associated virus 2 infection in children with non-A-E hepatitis.
Not available
S-EPMC7617659
|
biostudies-literature
Cite
Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C).
Not available
S-EPMC11586762
|
biostudies-literature
Cite
Genomic investigations of unexplained acute hepatitis in children.
Not available
S-EPMC10170458
|
biostudies-literature
Cite
Immunity to Streptococcus pyogenes and Common Respiratory Viruses at Age 0 to 4 Years After COVID-19 Restrictions.
Not available
S-EPMC12529189
|
biostudies-literature
Cite
Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema.
Not available
S-EPMC9896372
|
biostudies-literature
Cite
Evaluation of Autoantibody Binding to Cardiac Tissue in Multisystem Inflammatory Syndrome in Children and COVID-19 Vaccination-Induced Myocarditis.
Not available
S-EPMC10196878
|
biostudies-literature
Cite
Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT).
Not available
S-EPMC4898313
|
biostudies-literature
Cite
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
Not available
S-EPMC9714135
|
biostudies-literature
Cite
Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans.
Not available
S-EPMC4572072
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets